Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.
about
The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membraneThe role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung diseaseProgranulin in frontotemporal lobar degeneration and neuroinflammationWFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lungSecretory leukocyte protease inhibitor is an inducible antimicrobial peptide expressed in Staphylococcus aureus endophthalmitisCyclophilin C-associated protein: a normal secreted glycoprotein that down-modulates endotoxin and proinflammatory responses in vivoAnti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitorInvolution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitroThe Role of Serine Proteases and Antiproteases in the Cystic Fibrosis LungPotential mechanisms of progranulin-deficient FTLDPotential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairmentSecretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 InfectionSecretory Leukoprotease Inhibitor: A Native Antimicrobial Protein in the Innate Immune Response in a Rat Model ofS. aureusKeratitisAntimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implicationsActivation of interleukin-1 receptor-associated kinase by gram-negative flagellinHuman papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitorStructure of the murine secretory leukoprotease inhibitor (Slpi) gene and chromosomal localization of the human and murine SLPI genesTherapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with a half-sized secretory leukocyte protease inhibitor or the nonsteroidal anti-inflammatory drug diclofenac sodium against Mycobacterium avium complex infecSecretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritisIncreased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient miceInflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesisChanges in salivary proteome following allogeneic hematopoietic stem cell transplantation.Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease.Chronic hyperbaric exposure activates proinflammatory mediators in humans.Beneficial effects of secretory leukocyte protease inhibitor after spinal cord injury.Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient miceAnti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor.Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitorInduction of adrenomedullin mRNA and protein by lipopolysaccharide and paclitaxel (Taxol) in murine macrophages.Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunityDiverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway.Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing.Toll-like receptors: molecular mechanisms of the mammalian immune response.Host immune response to Salmonella enterica serovar Typhimurium infection in mice derived from wild strainsLipopolysaccharide priming enhances expression of effectors of immune defence while decreasing expression of pro-inflammatory cytokines in mammary epithelia cells from cows.The level of secretory leukocyte protease inhibitor is decreased in metastatic head and neck squamous cell carcinoma.Regulation of progranulin expression in human microglia and proteolysis of progranulin by matrix metalloproteinase-12 (MMP-12).Aberrant host defense against Leishmania major in the absence of SLPI.Heat shock proteins and heat adaptation of the whole organism.
P2860
Q21143809-DCDA5AEB-EA06-46A3-A1CC-A4BEB800235DQ21146748-88F0FFA4-C441-488B-B65A-7E90DF0F359BQ21245242-31EF8BAF-A36A-4EF5-8573-0ED7C0F1F57EQ21284411-869F0388-16A6-465C-A87F-0CE4FA894439Q21342956-80435593-C79E-4722-9D96-86BE08C0E5DBQ24672890-A101D895-9C8A-48DC-BB67-EDEF786CCE01Q24681571-1B0D1864-3FB9-4A0F-96AC-8CCDB026BDACQ24794211-2FAFEE6E-0F47-4A17-B208-B6A1BDD6254EQ24799057-F6ECE622-AB62-46D6-AAE8-64E2842328D2Q26799771-FB441508-86BA-4961-8444-FB8A113CB6E2Q26863702-8AD64528-E9FC-4897-85E5-55DB8CC26703Q27011876-51164B67-3318-4546-9C0A-855FA1F8CCD3Q27485184-6465364F-20DF-46B2-B9A4-44C1F4C8C413Q27495900-704AFAF4-41A4-4563-976F-2BF8BC206913Q28087327-1BE80CEF-CA08-4F90-917F-B961E7624581Q28201436-2847CD67-4C9B-40D0-9F83-CFA82E717239Q28286766-F10BA8BD-F772-4FAC-90D5-EA1D229DF941Q28290820-8AB97326-3B62-4EAB-9E9F-A231053CB7E4Q28369588-C1A9CA9A-DA34-4138-AFCA-0AE28EE9CC14Q28572864-591DA5F9-10D9-4AA9-BB5E-7BCD30686ECBQ28588786-8CC9CD14-67BA-4A22-9840-DF048CA244EFQ29622851-35508E9E-D28C-4631-A740-7B89095DF66EQ33270568-413354EF-77BA-4618-87F8-BED6F20196EDQ33345163-332E7E9D-ADF2-4AB9-B3B4-7B097E26FC59Q33425268-77C21194-F3A9-4F1A-84AF-89660CC7A907Q33570020-7120DCFD-492F-4ED6-B02C-E8CDF13365B1Q33615151-55126579-6EFD-4464-934C-F7EDC69FCB2BQ33715960-CDE7D89B-2BF5-44CD-AA76-BDB2463155FDQ33754239-DAF338CA-CA56-4C48-AD28-4C2F0DFD9039Q33764530-2D9A229E-E192-46C3-9AEF-97272126D768Q33780434-3299489B-80E2-49A0-A182-863D9D657163Q33797156-CC326C89-9421-42F9-BB3F-D808D748FD7DQ33920067-5AF7518F-C93A-4201-8418-90797E213795Q34049969-13FCE169-9BDE-4328-AF9F-6078C0680767Q34120673-8E393EA7-03E2-49B9-A048-21738681077BQ34124078-C81F75C4-E9BF-43F2-888A-2F76F0DFCDA5Q34181948-C246CF84-1C75-4F81-A4CF-1230ECFE4CC1Q34235574-ECA1F154-356A-4886-A10C-79A014B378F4Q34341332-DC89BAF3-6E89-4103-9AFF-AA972E4037BFQ34447069-1B3A633B-CFBF-4A85-9EAC-37475D9C8021
P2860
Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Secretory leukocyte protease i ...... bacterial lipopolysaccharide.
@en
type
label
Secretory leukocyte protease i ...... bacterial lipopolysaccharide.
@en
prefLabel
Secretory leukocyte protease i ...... bacterial lipopolysaccharide.
@en
P2093
P1433
P1476
Secretory leukocyte protease i ...... o bacterial lipopolysaccharide
@en
P2093
P304
P356
10.1016/S0092-8674(00)81880-2
P407
P577
1997-02-01T00:00:00Z